Zkbio Access Ivs
CVE-2024-1706
LOW
Vulnerability Assessment
| Weakness |
CWE
OWASP Top 10:2025
A05:2025 - Injection
ASVS 5.0
V1 - Encoding and Sanitization Output encoding, context-aware escaping
MITRE ATT&CK
2 techniques across 2 tactics: Initial Access, Execution The technique list with ATT&CK links and the kill-chain view is part of the Basic plan and up. |
| Impact | CVSS score of 2.0 (LOW). Attack characteristics: network attack vector, low complexity, low privileges required, user interaction required. EPSS exploitation probability: 0.11%. |
| Exploit ScenarioDerived | A remote attacker could inject malicious scripts into web pages viewed by other users by sending crafted requests to the affected application. |
Get an e-mail when this CVE is exploited, patched or re-scored. Free account.
Alert meAnalysisAI
A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. Rated low severity (CVSS 2.0), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Sanitize all user input, use Content-Security-Policy headers, encode output contextually (HTML, JS, URL). Use frameworks with built-in XSS protection.
Affects your stack
Find out whether the stacks and servers you run are on an affected version.
Checking this CVE against your own stacks and servers is part of the Basic plan and up.
Technical ContextAI · show details
This vulnerability is classified as Cross-Site Scripting (XSS) (CWE-79), which allows attackers to inject malicious scripts into web pages viewed by other users. A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input <marquee>hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer. Affected products include: Zkteco Zkbio Access Ivs. Version information: up to 3.3.2..
Know when Zkbio Access Ivs gets its next vulnerability
- Watch products and get an email when something new is published
- Check this CVE against your own stack and servers
- Exploit and PoC references, threat intelligence from 22 sources
No credit card · 7-day full trial
Severity by source
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
DescriptionCVE.org
A vulnerability was determined in ZKTeco ZKBio Access IVS up to 3.3.2. This impacts an unknown function of the component Department Name Search Bar. This manipulation with the input <marquee>hi causes cross site scripting. Remote exploitation of the attack is possible. The exploit has been publicly disclosed and may be utilized. The vendor explains: "ZKBio Access IVS is no longer maintained and the product has been replaced by ZKBio CVAccess, it is recommended to replace it with the latest version of ZKBio CVAccess." This vulnerability only affects products that are no longer supported by the maintainer.
Threat Intelligence Overview
NVD
CVE.org
EPSS
VulDB
How this decision was reached
The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.
What every action level means
SSVC AssessmentENISA
Priority Score
Attack Technique
Cross-Site Scripting occurs when an application accepts untrusted data and sends it to a web browser without proper validation or encoding.
GitHub PoC
Exploit-DB